(Reuters) -Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve claims over alleged quality control lapses in medicine to treat attention deficit hyperactivity disorder in children, Texas Attorney General Ken Paxton said on Wednesday.
(Reporting by Jonathan Stempel in New York)
Brought to you by www.srnnews.com
